Latest Breaking News On - Latant amgn us0311621009 - Page 1 : comparemela.com

The U.S. Supreme Court on Monday is set to hear a bid by Amgen Inc to revive patents on its cholesterol-lowering drug Repatha in a legal effort that rival Sanofi SA called a blatant attempt to squeeze. | March 27, 2023

United statesJoe bidenJohn kruzelAndrew chungAmgen incRegeneron pharmaceuticals incUs courtUs supreme court onRegeneron pharmaceuticalsCalifornia based amgenFederal circuitWill dunhamAmgen inc stock exchangePress releaseLatant amgn us0311621009